Free Trial

Clene (CLNN) Competitors

Clene logo
$3.66 -0.08 (-2.14%)
Closing price 07/24/2025 03:59 PM Eastern
Extended Trading
$3.78 +0.13 (+3.42%)
As of 08:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLNN vs. FTLF, TARA, KRRO, SKYE, ACTU, ALTS, ATOS, CLLS, BHST, and TNYA

Should you be buying Clene stock or one of its competitors? The main competitors of Clene include FitLife Brands (FTLF), Protara Therapeutics (TARA), Korro Bio (KRRO), Skye Bioscience (SKYE), Actuate Therapeutics (ACTU), ALT5 Sigma (ALTS), Atossa Genetics (ATOS), Cellectis (CLLS), BioHarvest Sciences (BHST), and Tenaya Therapeutics (TNYA). These companies are all part of the "pharmaceutical products" industry.

Clene vs. Its Competitors

Clene (NASDAQ:CLNN) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Clene has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500.

FitLife Brands has a net margin of 13.85% compared to Clene's net margin of -8,306.00%. FitLife Brands' return on equity of 25.59% beat Clene's return on equity.

Company Net Margins Return on Equity Return on Assets
Clene-8,306.00% N/A -105.11%
FitLife Brands 13.85%25.59%15.26%

FitLife Brands has higher revenue and earnings than Clene. Clene is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clene$340K89.02-$39.40M-$4.04-0.91
FitLife Brands$64.47M1.93$8.98M$0.8415.80

In the previous week, FitLife Brands had 1 more articles in the media than Clene. MarketBeat recorded 4 mentions for FitLife Brands and 3 mentions for Clene. FitLife Brands' average media sentiment score of 1.05 beat Clene's score of 0.63 indicating that FitLife Brands is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clene
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
FitLife Brands
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Clene currently has a consensus target price of $40.00, suggesting a potential upside of 992.90%. FitLife Brands has a consensus target price of $20.50, suggesting a potential upside of 54.48%. Given Clene's higher probable upside, equities research analysts plainly believe Clene is more favorable than FitLife Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clene
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17
FitLife Brands
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

23.3% of Clene shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 35.3% of Clene shares are owned by company insiders. Comparatively, 61.4% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

FitLife Brands beats Clene on 12 of the 16 factors compared between the two stocks.

Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLNN vs. The Competition

MetricCleneMED IndustryMedical SectorNASDAQ Exchange
Market Cap$30.92M$3.05B$5.72B$9.47B
Dividend YieldN/A2.40%4.60%3.99%
P/E Ratio-0.9120.8627.9419.95
Price / Sales89.02317.05452.94100.82
Price / CashN/A43.2336.5558.97
Price / Book-3.458.308.645.90
Net Income-$39.40M-$55.19M$3.24B$258.42M
7 Day Performance-4.19%5.81%3.69%2.11%
1 Month Performance-10.73%17.73%10.33%12.44%
1 Year Performance-17.94%4.67%34.30%19.55%

Clene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLNN
Clene
3.4454 of 5 stars
$3.66
-2.1%
$40.00
+992.9%
-19.2%$30.92M$340K-0.91100
FTLF
FitLife Brands
4.277 of 5 stars
$13.09
+0.5%
$20.50
+56.6%
-20.0%$122.92M$64.47M15.5820News Coverage
Positive News
TARA
Protara Therapeutics
2.0779 of 5 stars
$3.16
+3.6%
$20.50
+548.7%
+44.0%$121.91MN/A-1.8430Positive News
KRRO
Korro Bio
1.8772 of 5 stars
$12.97
+2.0%
$102.43
+689.7%
-67.0%$121.79M$2.27M-1.3770News Coverage
Analyst Forecast
SKYE
Skye Bioscience
1.8633 of 5 stars
$3.93
-1.3%
$16.60
+322.4%
-32.7%$121.73MN/A-4.7911News Coverage
ACTU
Actuate Therapeutics
2.275 of 5 stars
$6.20
+1.0%
$20.50
+230.6%
N/A$121.64MN/A0.0010
ALTS
ALT5 Sigma
0.1425 of 5 stars
$6.96
-11.7%
N/A+262.2%$121.45M$12.53M0.00170
ATOS
Atossa Genetics
3.0813 of 5 stars
$0.94
-0.2%
$6.17
+558.4%
-38.4%$120.98MN/A-4.468News Coverage
Positive News
CLLS
Cellectis
2.8161 of 5 stars
$2.15
+35.2%
$4.00
+86.0%
-2.0%$119.50M$49.22M-2.50290Positive News
High Trading Volume
BHST
BioHarvest Sciences
N/A$7.05
-1.8%
$13.67
+93.9%
N/A$115.80M$27.70M-14.10N/ANews Coverage
TNYA
Tenaya Therapeutics
3.8444 of 5 stars
$0.71
+4.1%
$6.25
+778.5%
-77.2%$115.72MN/A-0.61110Positive News

Related Companies and Tools


This page (NASDAQ:CLNN) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners